CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
with either gemcitabine plus nab-paclitaxel (G/NP) or FOLFIRINOX in the treatment of participants with locally advanced, unresectable pancreatic...
Phase 3
Phoenix, Arizona, United States and 89 other locations
Bluestar Genomics has developed a non-invasive test that aids in detection of occult pancreatic cancer in patients with new onset t ...
Scottsdale, Arizona, United States and 4 other locations
Phase 1 Safety and Tolerability Study in Subjects with Pancreatic Cancer or Other CA19-9 Positive Malignancies....
Phase 1
Scottsdale, Arizona, United States and 4 other locations
drugs, Vemurafenib and Sorafenib, in individuals with KRAS mutated pancreatic cancer who have progressed on standard chemotherapy....
Phase 2
Scottsdale, Arizona, United States
A) vs. mFOLFIRINOX plus placebo (Arm B) in 94 subjects with advanced pancreatic cancer, not amenable to curative treatment. Both ar...
Phase 2
Scottsdale, Arizona, United States and 7 other locations
doses of L-DOS47 in combination with doxorubicin, as well as preliminary anti-tumor activity in patients with previously treated advanced pancreatic...
Phase 1, Phase 2
Scottsdale, Arizona, United States and 2 other locations
A Phase 1/1b dose finding study to determine the OBD(s) and RP2D(s) of BMF-219, a covalent menin inhibitor small molecule, in subjects with KRAS muta...
Phase 1
Goodyear, Arizona, United States and 22 other locations
This is a Phase 1b/2, open-label, multi-center, competitive enrollment and dose-escalation study of HCW9218 in patients with advanced/metastatic pancreatic...
Phase 1, Phase 2
Scottsdale, Arizona, United States and 4 other locations
compared to just chemotherapy alone in participants with metastatic pancreatic cancer. One group of participants will only receive ...
Phase 2
Scottsdale, Arizona, United States and 35 other locations
This proposed Phase I clinical trial of SON-DP is an FIH, open-label, Phase Ia/Ib dose escalation and expansion study to evaluate the safety, tolerab...
Phase 1
Gilbert, Arizona, United States and 4 other locations
Clinical trials
Research sites
Resources
Legal